4.7 Article

p38 MAPK signaling acts upstream of LIF-dependent neuroprotection during photoreceptor degeneration

期刊

CELL DEATH & DISEASE
卷 4, 期 -, 页码 -

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/cddis.2013.323

关键词

leukemia inhibitory factor (LIF); p38 MAPK; TNF; Muller glia cell; photoreceptor; neuroprotection

资金

  1. Swiss National Science Foundation
  2. Velux Foundation

向作者/读者索取更多资源

In many blinding diseases of the retina, loss of function and thus severe visual impairment results from apoptotic cell death of damaged photoreceptors. In an attempt to survive, injured photoreceptors generate survival signals to induce intercellular protective mechanisms that eventually may rescue photoreceptors from entering an apoptotic death pathway. One such endogenous survival pathway is controlled by leukemia inhibitory factor (LIF), which is produced by a subset of Muller glia cells in response to photoreceptor injury. In the absence of LIF, survival components are not activated and photoreceptor degeneration is accelerated. Although LIF is a crucial factor for photoreceptor survival, the detailed mechanism of its induction in the retina has not been elucidated. Here, we show that administration of tumor necrosis factor-alpha (TNF) was sufficient to fully upregulate Lif expression in Muller cells in vitro and the retina in vivo. Increased Lif expression depended on p38 mitogen-activated protein kinase (MAPK) since inhibition of its activity abolished Lif expression in vitro and in vivo. Inhibition of p38 MAPK activity reduced the Lif expression also in the model of light-induced retinal degeneration and resulted in increased cell death in the light-exposed retina. Thus, expression of Lif in the injured retina and activation of the endogenous survival pathway involve signaling through p38 MAPK.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biotechnology & Applied Microbiology

Endosomal disentanglement of a transducible artificial transcription factor targeting endothelin receptor A

Claudia C. Bippes, Corina Kohler, Esther Garcia-Tirado, Reto Burri, Tina Frauenknecht, Marie-Apolline Gerard, Marie Salat, Roy Allenspach, Cavit Agca, Zongsong Wu, Andrea Trost, Barbara Bogner, Peter Meyer, Hendrik P. N. Scholl, Herbert Reitsamer, Josef Flammer, Albert Neutzner

Summary: Cell-penetrating peptides (CPPs) have great potential for intracellular delivery of therapeutic proteins, but endosomal entrapment hinders their successful application. By utilizing endosome-resident proteases to sever the artificial transcription factor from its CPP, we enhanced the subcellular localization and biological activity of the disentangled artificial transcription factor.

MOLECULAR THERAPY (2022)

Article Biology

Single-cell RNA sequencing of the retina in a model of retinitis pigmentosa reveals early responses to degeneration in rods and cones

Duygu Karademir, Vyara Todorova, Lynn J. A. Ebner, Marijana Samardzija, Christian Grimm

Summary: This study utilizes droplet-based single-cell RNA sequencing to investigate the degeneration process in rod and cone photoreceptor cells in an RP mouse model. The results identify early changes in rods and potential early responses in cones, suggesting mechanisms involved in secondary cone degeneration. Furthermore, the study implicates EGR1 as a potential key regulator of early degenerative events in both types of photoreceptor cells.

BMC BIOLOGY (2022)

Article Biochemistry & Molecular Biology

Regulation of ABCA1 by AMD-Associated Genetic Variants and Hypoxia in iPSC-RPE

Florian Peters, Lynn J. A. Ebner, David Atac, Jordi Maggi, Wolfgang Berger, Anneke den Hollander, Christian Grimm

Summary: This study focuses on analyzing the dysregulation of ATP-binding cassette transporter A1 (ABCA1) in induced pluripotent stem cell (iPSC)-derived retinal pigment epithelium (RPE) cells. The results show that genetic variations associated with age-related macular degeneration (AMD) result in increased ABCA1 gene expression, reduced cholesterol efflux, and increased lipid accumulation. Additionally, hypoxia decreases ABCA1 expression and increases intracellular lipid accumulation. Stimulating ABCA1 expression could improve RPE cell survival and reduce the risk of developing AMD.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Medicine, Research & Experimental

Systemic and local immune responses to intraocular AAV vector administration in non-human primates

Divya Ail, Duohao Ren, Elena Brazhnikova, Celine Nouvel-Jaillard, Stephane Bertin, Seyed Bagher Mirashrafi, Sylvain Fisson, Deniz Dalkara

Summary: This study investigates the potential inflammatory responses in AAV-mediated retinal gene therapy and the correlation between pre-existing serum antibodies and clinical outcomes. The results show a dose-dependent increase in antibodies after injection, and a correlation between serum antibody levels, inflammation, and transgene expression.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2022)

Article Biochemistry & Molecular Biology

Increased H3K27 trimethylation contributes to cone survival in a mouse model of cone dystrophy

Annie L. Miller, Paula Fuller-Carter, Klaudija Masarini, Marijana Samardzija, Kim W. Carter, Rabab Rashwan, Xin Ru Lim, Alicia A. Brunet, Abha Chopra, Ramesh Ram, Christian Grimm, Marius Ueffing, Livia S. Carvalho, Dragana Trifunovic

Summary: Inherited retinal diseases (IRDs) are a group of blinding disorders that affect the cone and rod photoreceptors. This study explores the potential therapeutic benefits of a histone demethylase inhibitor, GSK-J4, on cone cell survival in a mouse model of achromatopsia. The results suggest that epigenetic modulation of histones may be a promising approach in slowing down cone degeneration in IRDs.

CELLULAR AND MOLECULAR LIFE SCIENCES (2022)

Article Neurosciences

Stanniocalcin2, but Not Stanniocalcin1, Responds to Hypoxia in a HIF1-Dependent Manner in the Retina

Divya Ail, Marijana Samardzija, Andy C. M. Chang, Jadwiga Keck, Roger R. Reddel, Christian Grimm

Summary: This study investigated the expression of stanniocalcins in the retina and found that Stc2 was induced in acute and chronic hypoxia models, regulated by HIF1, while Stc1 remained stable. Furthermore, Stc2 was expressed in the inner retina, rather than in photoreceptors.

FRONTIERS IN NEUROSCIENCE (2022)

Article Biochemistry & Molecular Biology

HIF1 and DROSHA are involved in MMACHC repression in hypoxia

Eva Kiessling, Florian Peters, Lynn J. A. Ebner, Luca Merolla, Marijana Samardzija, Matthias R. Baumgartner, Christian Grimm, Sean Froese

Summary: The MMACHC gene encodes an enzyme involved in vitamin B12 metabolism. Oxidative stress may impair vitamin B12 metabolism by suppressing MMACHC expression.

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2022)

Review Neurosciences

Gene regulatory and gene editing tools and their applications for retinal diseases and neuroprotection: From proof-of-concept to clinical trial

Halit Yusuf Altay, Fatma Ozdemir, Ferdows Afghah, Zeynep Kilinc, Mehri Ahmadian, Markus Tschopp, Cavit Agca

Summary: Gene editing and gene regulatory fields are advancing, with a focus on retinal diseases in ophthalmology. Novel gene editing tools and gene regulatory approaches have the potential to overcome limitations in current gene replacement therapies and offer safer alternatives.

FRONTIERS IN NEUROSCIENCE (2022)

Review Pharmacology & Pharmacy

Immune Responses to Gene Editing by Viral and Non-Viral Delivery Vectors Used in Retinal Gene Therapy

Duohao Ren, Sylvain Fisson, Deniz Dalkara, Divya Ail

Summary: Inherited retinal diseases are a major cause of blindness, and gene therapy using gene editing techniques like CRISPR-Cas9 shows promise for their treatment. However, ocular gene therapies can elicit immune responses that need to be managed to ensure safe and effective gene editing.

PHARMACEUTICS (2022)

Article Multidisciplinary Sciences

Retinal Layer Separation (ReLayS) method enables the molecular analysis of photoreceptor segments and cell bodies, as well as the inner retina

Vyara Todorova, Luca Merolla, Duygu Karademir, Gabriele M. Wogenstein, Julian Behr, Lynn J. A. Ebner, Marijana Samardzija, Christian Grimm

Summary: Understanding the physiology of the retina, particularly the highly polarized photoreceptors, is crucial for advancing our knowledge of normal vision processes and developing effective therapies for retinal degenerative diseases. However, studying the molecular mechanisms of photoreceptors is challenging due to the heterogeneity of retinal tissue and the lack of reliable cell separation methods. In this study, the researchers present a simple technique called ReLayS that successfully separates different parts of photoreceptors, enabling protein and RNA analysis. The method was validated using known proteins and genes and also revealed light-driven translocation of transducin.

SCIENTIFIC REPORTS (2022)

Editorial Material Neurosciences

Editorial: Neuroprotective mechanisms and translational approaches in the retina

Afsun Sahin, Markus Tschopp, Cavit Agca

FRONTIERS IN NEUROSCIENCE (2023)

Article Neurosciences

Deficits in mitochondrial TCA cycle and OXPHOS precede rod photoreceptor degeneration during chronic HIF activation

Vyara Todorova, Mia Fee Stauffacher, Luca Ravotto, Sarah Notzli, Duygu Karademir, Lynn J. A. Ebner, Cornelia Imsand, Luca Merolla, Stefanie. M. M. Hauck, Marijana Samardzija, Aiman. S. S. Saab, L. Felipe Barros, Bruno Weber, Christian Grimm

Summary: This study investigates the pathological mechanisms of photoreceptor (PR) degeneration during chronic activation of hypoxia-inducible factors (HIFs). The results show that PR cells have an exceptionally high glycolytic flux and the activation of HIFs slows down the cellular anabolism, leading to the shortening of rod outer segments before cell degeneration.

MOLECULAR NEURODEGENERATION (2023)

Review Genetics & Heredity

Adeno-Associated Virus (AAV)-Based Gene Therapies for Retinal Diseases: Where are We?

Divya Ail, Hugo Malki, Emilia A. Zin, Deniz Dalkara

Summary: Due to their small size and safety profiles, adeno-associated viruses (AAVs) have become the preferred vector for retinal gene therapy. However, there are challenges such as limited packaging capacity, difficulties in crossing retinal barriers, and potential immune responses. This review focuses on the use of AAV in clinical trials for retinal diseases and strategies to overcome immune responses.

APPLICATION OF CLINICAL GENETICS (2023)

Article Multidisciplinary Sciences

Inducible nonhuman primate models of retinal degeneration for testing end-stage therapies

Divya Ail, Diane Nava, In Pyo Hwang, Elena Brazhnikova, Celine Nouvel-Jaillard, Alexandre Dentel, Corentin Joffrois, Lionel Rousseau, Julie Degardin, Stephane Bertin, Jose-Alain Sahel, Olivier Goureau, Serge Picaud, Deniz Dalkara

Summary: To test novel therapies, suitable nonhuman primate models are needed, but there is a lack of relevant macaque models of retinal degeneration. Researchers have generated three distinct inducible cynomolgus macaque models of retinal degeneration to address this issue. Among the three models, the CRISPR-Cas9-based approach is the most advantageous for recapitulating disease-specific features and ease of implementation. The acute model, on the other hand, degenerates the fastest and is the most relevant for testing end-stage vision restoration therapies.

SCIENCE ADVANCES (2023)

暂无数据